MGO One Seven LLC recently reduced its position in biotechnology firm Corcept Therapeutics by 8.2%, selling 551 shares and retaining 6,142 shares valued at $451,000. This adjustment, disclosed through an SEC filing, underscores the shifting landscape of institutional investments in biotech.

Bridgeway Capital Management LLC reduced its stake in Crescent Energy Company by 3.1% during the first quarter, selling 54,826 shares. The firm now holds over 1.7 million shares, according to its most recent SEC filing.

Mubadala Investment Co PJSC has trimmed its position in Gilead Sciences by 2.6%, according to a Form 13F filing with the SEC. The institutional investor sold 1,160 shares during the first quarter, retaining 42,748 shares of the biopharmaceutical firm.